BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8453704)

  • 21. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose ifosfamide in the treatment of advanced soft tissue sarcomas.
    Tursz T
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):34-9. PubMed ID: 8711500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of hematological growth factors to enable dose intensification in chemotherapy for soft tissue sarcomas.
    Liem GS; Verweij J
    Stem Cells; 1994 Jul; 12(4):402-8. PubMed ID: 7951007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
    Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chemotherapy for soft tissue sarcoma--current concepts and review].
    Umeda T; Ishii T; Hatakeyama K; Wakita H
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):1937-44. PubMed ID: 8215466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma.
    Pápai Z; Bodoky G; Szántó J; Poller I; Rahóty P; Eckhardt S; Láng I; Szendroi M
    Cancer; 2000 Jul; 89(1):177-80. PubMed ID: 10897015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy for advanced sarcoma: therapeutic decisions and modalities.
    Keohan ML; Taub RN
    Semin Oncol; 1997 Oct; 24(5):572-9. PubMed ID: 9344324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas.
    Nielsen OS; Reichardt P; Christensen TB; Pink D; Daugaard S; Hermans C; Marreaud S; van Glabbeke M; Blay J; Judson I
    Eur J Cancer; 2006 Sep; 42(14):2303-9. PubMed ID: 16891112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chemotherapy for pulmonary metastases of soft tissue sarcoma].
    Kito M; Umeda T
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1701-6. PubMed ID: 9757195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy for soft-tissue sarcomas.
    Elias AD
    Clin Orthop Relat Res; 1993 Apr; (289):94-105. PubMed ID: 8472436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacologic basis of ifosfamide use in adult patients with advanced soft tissue sarcomas.
    Tascilar M; Loos WJ; Seynaeve C; Verweij J; Sleijfer S
    Oncologist; 2007 Nov; 12(11):1351-60. PubMed ID: 18055856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas.
    Bokemeyer C; Franzke A; Hartmann JT; Schöber C; Arseniev L; Metzner B; Link H; Kanz L; Schmoll HJ
    Cancer; 1997 Oct; 80(7):1221-7. PubMed ID: 9317171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy of advanced sarcomas of bone and soft tissue.
    Antman KH
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):13-20. PubMed ID: 1485169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-intensive chemotherapy in advanced adult soft tissue sarcoma.
    Verma S; Bramwell V
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):201-15. PubMed ID: 12113242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current trials and new aspects in soft tissue sarcoma of adults.
    Issels RD; Schlemmer M
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Soft tissue sarcoma: postoperative chemotherapy].
    Goto T; Kosaku H; Kobayashi H; Hozumi T; Kondo T
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1324-30. PubMed ID: 15446551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative chemotherapy and split-course radiation therapy for patients with localized soft tissue sarcomas: home run, base hit, or strike out?
    Pisters PW
    J Clin Oncol; 2006 Feb; 24(4):549-51. PubMed ID: 16446327
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].
    Huang YH; Wen XP; Hu L
    Ai Zheng; 2002 Aug; 21(8):907-9. PubMed ID: 12478905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose therapy for adult soft tissue sarcoma: dose response and survival.
    Elias AD
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):19-23; discussion 45-8. PubMed ID: 9578058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.